8 Results for "

PI3Kα-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "PI3Kα-IN-1" in MCE Product Catalog:

Cat. No.: HY-124647
CAS No.: 2100855-80-7
Target:  

PI3K

Research Areas:  

Cancer

PI3Kα-IN-1 is a PI3Kα inhibitor (IC50 < 0.5 nM), and also inhibits mTOR (IC50: 104 nM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13531
CAS No.: 648449-76-7
Purity:  99.95%
Target:  

PI3K

Research Areas:  

Cancer

AS-604850 is a potent, selective and ATP-competitive PI3Kγ inhibitor with an IC50 value of 0.25 μM and a Ki value of 0.18 μM. AS-604850 shows isoform selective inhibitor of PI3Kγ with over 30-fold selectivity for PI3Kδ and β, and 18-fold selectivity over PI3Kα, respectively .
loading...
    loading...
Cat. No.: HY-174461
Target:  

PROTACs PI3K

Research Areas:  

Cancer

PROTAC PI3Kα degrader-1 is a PI3Kα PROTAC degrader that recruits CRBN, with a DC50 of 0.08 μM in T47D breast cancer cells. PROTAC PI3Kα degrader-1 inhibits the phosphorylation of AKT at the Ser 473 site in cancer cells and exhibits in vivo anticancer efficacy in xenograft models. PROTAC PI3Kα degrader-1 can be used in cancer-related research .
loading...
    loading...
Cat. No.: HY-174798
Research Areas:  

Cancer

PI3Kα Ligand-1 is the ligand for PI3Kα that can be used for synthesis of PROTACs, such as PI3Kα degrader-1 (HY-174461) .
loading...
    loading...
Cat. No.: HY-161968
Target:  

EGFR PI3K

Research Areas:  

Cancer

EGFR/PI3Kα-IN-1 (compound 30k) is a dual EGFR/PI3Kα inhibitor with IC50 values of 3.6 nM (EGFRL858R/T790M) and 30 nM (PI3Kα), respectively. EGFR/PI3Kα-IN-1 can inhibit tumor cell proliferation and has anticancer activity .
loading...
    loading...
Cat. No.: HY-163361
CAS No.: 228999-57-3
Target:  

PI3K

Research Areas:  

Cancer

PI3Kα-IN-20 (compound 2) is a selective PI3Kα inhibitor .
loading...
    loading...
Cat. No.: HY-W940885
CAS No.: 2716120-15-7
Research Areas:  

Cancer

Pomalidomide-NH-C13-OH is a synthesized E3 ligase ligand-linker conjugate that can be used for synthesis of PROTAC PI3Kα degrader-1 (HY-174461) .
loading...
    loading...
Cat. No.: HY-182083
Target:  

PROTACs PI3K

Research Areas:  

Cancer

PROTAC PI3Kα/δ degrader-1 is an orally active PI3Kα/δ PROTAC degrader, with an IC50 of 0.34 nM for PI3Kα and 1.85 nM for PI3Kδ. PROTAC PI3Kα/δ degrader-1 inhibits the proliferation and migration of cancer cells, induces G1-phase cell cycle arrest and PI3Kα degradation. PROTAC PI3Kα/δ degrader-1 suppresses tumor growth in breast cancer xenograft mouse models. PROTAC PI3Kα/δ degrader-1 can be used for the research of breast cancer .
loading...
    loading...